PROVIDER PROFILE · NPI 1922096031

Mary Ellen MartinMD

Hematology-OncologyPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

101

Distinct HCPCS

Medicare payment

$9K

Peer benchmark

Total Medicare services vs. 417 Hematology-Oncology providers in PA — bottom quintile (cohort median 753).

PRESCRIBING · PART D · 2024

Total Rx claims

116

Beneficiaries

—

Total drug cost

$1.2M

Distinct drugs

Brand share

52.6%

Top prescribed drugs

Acyclovir28 claims

Belumosudil Mesylate25 claims

Ruxolitinib Phosphate24 claims

Pantoprazole Sodium15 claims

Escitalopram Oxalate12 claims

QUALITY · MIPS · 2024

Final MIPS score

84.9

Quality

73.6

Cost

76.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.42%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$288

Payment records

By payment type

Food and Beverage$288

REFERRAL NETWORK

Where Mary Ellen Martin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Patricia Kropf Hematology · Charlotte, NC	22	119
Henry Fung Hematopoietic Cell Transplantation and Cellular Therapy · Philadelphia, PA	16	80
Stefan Barta Hematology-Oncology · Philadelphia, PA	12	42
CAPUTO, LARRY	12	26
Linda Perry Physician Assistant · Philadelphia, PA	11	85

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history